Total Payments
$10,176
2024 Payments
$414.73
Companies
30
Transactions
569
Medicare Patients
1,117
Medicare Billing
$129,330
Payment Breakdown by Category
Food & Beverage$10,025 (98.5%)
Education$151.44 (1.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,025 | 541 | 98.5% |
| Education | $151.44 | 28 | 1.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,732 | 147 | $0 (2024) |
| Amarin Pharma Inc. | $1,630 | 82 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $1,158 | 58 | $0 (2024) |
| Lilly USA, LLC | $1,079 | 51 | $0 (2024) |
| Amgen Inc. | $1,011 | 52 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $724.72 | 32 | $0 (2021) |
| SANOFI-AVENTIS U.S. LLC | $673.51 | 38 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $253.51 | 12 | $0 (2023) |
| Merck Sharp & Dohme Corporation | $252.29 | 14 | $0 (2021) |
| Astellas Pharma US Inc | $228.35 | 10 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $414.73 | 19 | Novo Nordisk Inc ($98.82) |
| 2023 | $547.88 | 26 | Lilly USA, LLC ($159.20) |
| 2022 | $881.39 | 38 | Lilly USA, LLC ($361.83) |
| 2021 | $743.73 | 45 | Novo Nordisk Inc ($239.46) |
| 2020 | $1,622 | 82 | Amarin Pharma Inc. ($460.27) |
| 2019 | $2,410 | 135 | Amarin Pharma Inc. ($408.74) |
| 2018 | $2,063 | 119 | Novo Nordisk Inc ($461.62) |
| 2017 | $1,494 | 105 | Amarin Pharma Inc. ($284.42) |
All Payment Transactions
569 individual payment records from CMS Open Payments — Page 1 of 23
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/03/2024 | Kowa Pharmaceuticals America, Inc. | ZORYVE (Drug) | Food and Beverage | In-kind items and services | $20.72 | General |
| Category: DERMATOLOGY | ||||||
| 11/05/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $22.49 | General |
| Category: Respiratory | ||||||
| 10/08/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $22.35 | General |
| Category: Respiratory | ||||||
| 09/17/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $19.13 | General |
| Category: Cardio-renal | ||||||
| 06/26/2024 | GlaxoSmithKline, LLC. | BEXSERO (Biological) | Food and Beverage | In-kind items and services | $23.04 | General |
| Category: VACCINES | ||||||
| 06/25/2024 | ConvaTec Inc. | GENTLECATH (Device) | Food and Beverage | In-kind items and services | $35.78 | General |
| Category: CONTINENCE CARE | ||||||
| 06/13/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.59 | General |
| Category: Diabetes | ||||||
| 06/12/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.58 | General |
| Category: Diabetes | ||||||
| 06/07/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $21.75 | General |
| Category: Cardio-renal | ||||||
| 05/29/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $16.77 | General |
| Category: Endocrinology | ||||||
| 05/22/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $25.93 | General |
| Category: Bone Health | ||||||
| 05/17/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $21.49 | General |
| Category: Diabetes | ||||||
| 05/10/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $23.00 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 04/20/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $25.04 | General |
| Category: Diabetes | ||||||
| 04/12/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $18.94 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 03/27/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $20.21 | General |
| Category: Diabetes | ||||||
| 03/06/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $22.55 | General |
| Category: Diabetes | ||||||
| 02/16/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.42 | General |
| Category: Cardio-renal | ||||||
| 02/07/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $17.95 | General |
| Category: Diabetes | ||||||
| 12/06/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $20.93 | General |
| Category: Diabetes | ||||||
| 11/03/2023 | Lilly USA, LLC | TRULICITY (Drug), MOUNJARO | Food and Beverage | In-kind items and services | $18.90 | General |
| Category: Diabetes | ||||||
| 11/01/2023 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $25.80 | General |
| Category: Endocrinology | ||||||
| 10/26/2023 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $21.77 | General |
| Category: VACCINES | ||||||
| 10/20/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.12 | General |
| Category: Diabetes | ||||||
| 09/27/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $21.75 | General |
| Category: Cardio-renal | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 257 | 723 | $111,009 | $42,144 |
| 2022 | 4 | 270 | 656 | $101,012 | $39,482 |
| 2021 | 2 | 277 | 653 | $105,300 | $27,101 |
| 2020 | 4 | 313 | 602 | $101,587 | $20,603 |
Total Patients
1,117
Total Services
2,634
Medicare Billing
$129,330
Procedure Codes
14
All Medicare Procedures & Services
14 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 212 | 674 | $99,689 | $38,036 | 38.2% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 12 | 12 | $4,802 | $2,056 | 42.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 18 | 22 | $4,947 | $1,942 | 39.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 15 | 15 | $1,571 | $109.53 | 7.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 206 | 581 | $86,152 | $34,047 | 39.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 33 | 44 | $9,894 | $3,677 | 37.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 11 | 11 | $2,977 | $1,558 | 52.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 20 | 20 | $1,989 | $200.81 | 10.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 202 | 547 | $81,464 | $21,560 | 26.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 75 | 106 | $23,836 | $5,541 | 23.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 187 | 411 | $60,414 | $12,132 | 20.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 96 | 159 | $35,739 | $6,649 | 18.6% |
| 99495 | Transitional care management services, moderately complexity, requiring face-to-face visits within 14 days of discharge | Office | 2020 | 11 | 12 | $3,393 | $1,602 | 47.2% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2020 | 19 | 20 | $2,042 | $218.65 | 10.7% |
About Dr. Daniel Harada, MD
Dr. Daniel Harada, MD is a Internal Medicine healthcare provider based in Aiea, Hawaii. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1689787996.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Harada, MD has received a total of $10,176 in payments from pharmaceutical and medical device companies, with $414.73 received in 2024. These payments were reported across 569 transactions from 30 companies. The most common payment nature is "Food and Beverage" ($10,025).
As a Medicare-enrolled provider, Harada has provided services to 1,117 Medicare beneficiaries, totaling 2,634 services with total Medicare billing of $129,330. Data is available for 4 years (2020–2023), covering 14 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Aiea, HI
- Active Since 08/17/2006
- Last Updated 09/28/2020
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1689787996
Products in Payments
- Vascepa (Drug) $1,630
- Ozempic (Drug) $681.73
- FARXIGA (Drug) $638.55
- TRULICITY (Drug) $512.73
- JARDIANCE (Drug) $468.77
- Prolia (Biological) $446.15
- Saxenda (Drug) $402.38
- EVENITY (Biological) $302.31
- BYDUREON (Drug) $291.19
- Victoza (Drug) $281.33
- MOUNJARO (Drug) $259.75
- ENTRESTO (Drug) $253.51
- JANUVIA (Drug) $252.29
- Kerendia (Drug) $200.46
- Aimovig (Biological) $198.72
- MYRBETRIQ (Drug) $193.96
- TOUJEO (Drug) $193.71
- SOLIQUA 100/33 (Drug) $148.09
- SPIRIVA RESPIMAT (Drug) $144.04
- STIOLTO RESPIMAT (Drug) $137.55
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Aiea
Roy Ebisu, Md, MD
Internal Medicine — Payments: $18,765
Internal Medicine $18,765
Stephen Miyasato, Md, MD
Internal Medicine — Payments: $18,084
Internal Medicine $18,084
Dr. Francis Buto, M.d, M.D
Internal Medicine — Payments: $14,868
Internal Medicine $14,868
Dr. Alan Oki, Md, MD
Internal Medicine — Payments: $14,573
Internal Medicine $14,573
Mark Nishihara, M.d, M.D
Internal Medicine — Payments: $14,206
Internal Medicine $14,206
Dr. Malissa Iida-Takashima, Md, MD
Internal Medicine — Payments: $13,761
Internal Medicine $13,761